REDWIL: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Completed
CT.gov ID
NCT01049971
Collaborator
(none)
109
1
2
37
2.9

Study Details

Study Description

Brief Summary

Surgical site infection is common in colorectal surgery leading to increased postoperative pain, longer hospital stay, delayed wound healing and increased re-operation rates. Hence, reducing the wound infection rate is a major aim in abdominal surgery.

Wound protectors were invented for retracting the abdominal wall and keeping the abdominal wall sterile in order to reduce bacterial colonialization of the wound and wound infections.

This is a prospective-randomized trial comparing use of wound protectors versus woven drapes in laparoscopic colon resections with minilaparotomy.

Condition or Disease Intervention/Treatment Phase
  • Device: wound protector
  • Device: no wound protector
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
109 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors
Study Start Date :
Dec 1, 2007
Actual Primary Completion Date :
Jan 1, 2011
Actual Study Completion Date :
Jan 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: no wound protector

instead of wound protector, a woven drape is applied

Device: no wound protector
use of woven drape instead of wound protector

Experimental: wound protector

after minilaparotomy, wound protector is applied

Device: wound protector
after minilaparotomy, the wound protector is applied
Other Names:
  • Vi-Drape (Trademark) wound protector
  • Outcome Measures

    Primary Outcome Measures

    1. percentage of wound infections [6 months postoperatively]

      the total percentage of wound infections within 6 months postoperatively will be analyzed

    Secondary Outcome Measures

    1. colonialization of abdominal wall with bacteria [6 months postoperatively]

      a swab of the abdominal wall is taken before skin closure routinely in every participating patient and the bacteria found is analyzed

    2. postoperative costs [6 months postoperatively]

      the costs for the operation, for the hospital stay including re-admissions, and for the outpatient stay is analyzed

    3. length of hospital stay [6 months postoperatively]

      the total hospital stay including re-admissions is analyzed

    4. cosmetic result [6 months postoperatively]

      the satisfaction with the cosmeti result is analyzed in every patient by questionnaire 6 months postoperatively

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • elective laparoscopic colorectal resection with minilaparotomy
    Exclusion Criteria:
    • emergency operation

    • patients under 18 years of age

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Charité Campus Benjamin Franklin; Hindenburgdamm 30 Berlin Germany 12200

    Sponsors and Collaborators

    • Charite University, Berlin, Germany

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01049971
    Other Study ID Numbers:
    • EA4/089/07
    First Posted:
    Jan 15, 2010
    Last Update Posted:
    Jul 7, 2011
    Last Verified:
    Dec 1, 2007

    Study Results

    No Results Posted as of Jul 7, 2011